ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,486,312, issued on Dec. 2, was assigned to ALPINE IMMUNE SCIENCES INC. (Seattle).
"Immunomodulatory proteins with tunable affinities" was invented by Ryan Swanson (Seattle) and Michael Kornacker (Seattle).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are immunomodulatory proteins and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological and oncological conditions. Compositions and methods for making and using such proteins are provided."
The patent was filed on March 29, 2022, under Application No. 17/707,511.
*For further information, including images, charts and tables,...